The NIH COVID-19 Treatment Guidelines Panel, more correctly referred to as The NIH COVID-19 Non-treatment panel (“NICHT”), was clandestinely created by Dr. Anthony Fauci in late March, and announced itself when it published its guidelines, on April 21. It is unclear by what authority Dr. Fauci convened it.
Big Tech Must Stop Blocking Health Information
Employees and/or contractors of Google, Facebook, Twitter, and Microsoft frequently remove doctors’ advice and medical information, simply because it is supported by the President. This is unacceptable at any time, but it is especially horrific when done during an emergency and when it interferes with life-saving treatments. Continue reading Big Tech Must Stop Blocking Health Information
Drafts
It is remarkable how the axis of Democrat Party – Fake News – Big Tech attempt to slow down approval and roll out of a vaccine against COVID-19, especially in light of their love of vaccination. Combined with their opposition to all other effective treatment and preventative measures, it seems they want the pandemic to rage in order to keep the lockdowns and other life disruptions until January 21, 2021, and beyond.
Masking is for Antifa
Mandatory masking is good only for Antifa. It allows Antifa thugs to blend in the population. Continue reading Drafts
Recently Published
“Remdesivir for COVID-19” Study accidentally proved effectiveness of Hydroxychloroquine was published in WUWT on October 26.
Does Universal Mask Wearing Decrease or Increase the Spread of COVID-19? was published in WUWT on July 26. The answer is ‘Increase‘. Masks spread COVID-19.
How to End the COVID-19 Epidemic in the US was published in AT on July 14. Continue reading Recently Published
COVID-19 Panel Gilead Ties
October 25: This corrupt panel nixes all treatments competing against Gilead’s remdesivir. It even recommends against prophylaxis – any prophylaxis!
September 22: H. Clifford Lane, a Co-Chair of the Panel, is a co-author of the fraudulent NIAID study of Remdesivir (Beigel et al., May 22), which served the Panel as an excuse to recommend the use of Remdesivir. He has not disclosed co-authorship. Undisclosed ties of two other Co-Chairs (Roy M. Gulick and Henry Masur) to Gilead are listed below. Continue reading COVID-19 Panel Gilead Ties
Google Tracking on .GOV websites
Federal government websites contain Google beacons and analytics files that allow Google to track visitors and gain information on them. Does this concern anyone? Continue reading Google Tracking on .GOV websites
NEJM Day: Boosting RDV, Attacking HCQ
2020-10-18 update: even the SOLIDARITY trial, conducted by pro-Gilead WHO, found Remdesivir ineffective for COVID-19.
On October 8, the New England Journal of Medicine fired a new salvo against Hydroxychloroquine. It published the results of a tragicomic RECOVERY trial, and the “final report” of NIAID study of Gilead’s Remdesivir (Remdeathsivir).
The fake news media treats this RECOVERY paper as news, and claims it proves that HCQ does not help severe patients. In fact these results were published in the media on June 4. The RECOVERY researchers severely overdosed and poisoned their patients with HCQ. Even with such overdoses of HCQ, no adverse cardiac events occurred, which is consistent with other clinical data. Continue reading NEJM Day: Boosting RDV, Attacking HCQ
Nationwide Tele-Consulting for COVID-19
Rehobot Medical Center / Dr. Stella (281-530-1230) – 25 states
doctalkgo.com (866-403-8714) and speakwithanmd.com (855-503-2657) might be able to prescribe Hydroxychloroquine-based treatment for COVID-19 symptoms in a tele-consulting, and even to have the medications delivered.
omariasinelabeconcepta.wordpress.com is no longer available.
Updated. Originaly published on Aug 16, 2020.
JAMA Rejected Comment to Abella et al.
HCWs taking HCQ for prophylaxis are more likely to expose themselves to COVID-19
Effectiveness of Hydroxychloroquine as preexposure prophylaxis against COVID-19 is well established. The normal regimen is 1,000-2,000 mg over 3-5 days, followed by 200-400 mg weekly Continue reading JAMA Rejected Comment to Abella et al.
President’s Health
President Trump is receiving sub-standard medical care and advice. Dr. Sean Conley, Physician to the President, received his DO (which is only slightly below MD) only 14 years ago. Before being assigned to the White House Medical Unit, he honorably served in the Navy, including overseas deployment(s). With all due respect, his rank is only that of Commander. Continue reading President’s Health
Cool but Misinterpreted HCQ PreP Study
Abella et al. [1] suggests that pre-exposure Hydroxychloroquine prophylaxis might protect a person against COVID-19, but to acquire immunity against it! Continue reading Cool but Misinterpreted HCQ PreP Study
Fauci Lied about Cross-Reactivity Study
Dr. Anthony Fauci brazenly lied to Senator Rand Paul, MD, when questioned about preexisting immunity to COVID-19, that some people have from coronavirus common colds. Existence of such cross-reactivity was not in doubt and was acknowledged by Dr. Fauci earlier. But on Wednesday, September 23, Dr. Fauci said “there was a study that recently came out that preexisting immunity to coronaviruses that are common cold do not cross-react with the covid-19”. Continue reading Fauci Lied about Cross-Reactivity Study
NIH Scientists Receive Royalties from Big Pharma
Under 15 U.S. Code § 3710c, federal researchers, whose work was patented and commercialized, receive royalties at the rate of at least 15% of what the US government receives from the licensees, capped at $150,000 per person, per year. NIH and CDC pay their scientists 25% (on amounts over $50,000). These royalties are paid even after the person leaves the government employment and continue after his or her death.
NIH, NIAID, or CDC researcher who contributed to the development of a novel drug or therapy, and was named as one of the inventors on a commercialized patent, may be entitled to $3 million in royalties over the 20-year lifespan of the patent. Continue reading NIH Scientists Receive Royalties from Big Pharma
Remdesivir has only insignificant antiviral effect against SARS-COV-2 but dangerous adverse events
version 2, 2020-09-20
Bullet Points
- In the recommended doses (200 mg on day 1, 100 mg per day after that), Remdesivir (RDV) has only insignificant antiviral effect against SARS-COV-2.
- RDV treatment in accordance with the current recommendations is likely to significantly increase mortality in severe COVID-19 patients.
- Only 3 (three) useful clinical trials have been cited by the FDA in the two EUAs they issued for RDV and by the NIH COVID-19 Treatment Panel in its recommendations to use RDV for COVID-19.
- Only one of the referenced studies claimed clinical benefits of RDV for COVID-19 patients, but it is invalidated by conflicts of interest, misleading reporting of results, suspicious data, and multiple significant changes in the protocol in the middle of the study
- The lack of RDV’s antiviral effect for SARS-COV-2 is consistent with the results of its trials for respiratory coronavirus on animals.
- The lack of RDV’s antiviral effect for SARS-COV-2 is also consistent with hindsight interpretation of early in vitro trials. RDV and Chloroquine (CQ) have shown similar selective antiviral effects in vitro. However, in vivo, CQ accumulates in lung tissue, while RDV does not. Even with this accumulation, CQ/HCQ is only effective in a synergetic combination with additional medicines, such as Azithromycin (AZ) and/or Zinc.
The Myth that HCQ Interferes with RDV
It is increasingly clear that on June 15, the FDA executed two coordinated attacks against Hydroxychloroquine (HCQ). One was the EUA revocation, supported by a junk science memo, and a press release saying “the FDA determined that chloroquine and hydroxychloroquine are unlikely to be effective in treating COVID-19 for the authorized uses in the EUA” (emphasis is added). The Big Tech and MSM distorted this already incorrect determination by omitting the last clause.
But within hours of this press release, the FDA issued another attack with a scary title Coronavirus (COVID-19) Update: FDA Warns of Newly Discovered Potential Drug Interaction That May Reduce Effectiveness of a COVID-19 Treatment Authorized for Emergency Use. This “update” started with Continue reading The Myth that HCQ Interferes with RDV
Death Rates Rise after the FDA Memo
The following chart shows the weekly number of deaths from all causes in the US, from January 1 till August 15 (snapshot from September 2). There was an increase in deaths from all causes after the anti-HCQ FDA’s memo from June 15.
HCQ is Effective and Approved
Hydroxychloroquine (HCQ) is approved by the FDA as an antimalarial and anti-rheumatic medication and can be prescribed by doctors for any disease. Neither the issuance nor the revocation of the Emergency Use Authorization (EUA) for HCQ has any impact on its status as an approved drug available for prescriptions. The EUA was only needed to use HCQ from the Strategic National Stockpile. Continue reading HCQ is Effective and Approved
Yes, there is a cure for COVID-19
The world has a cure for COVID-19. The current COVID-19 mortality in all countries of the Northern Hemisphere, except for Israel, is 4-40 times lower than in the US. Israel stopped using Hydroxychloroquine, probably under the influence of the Big Tech misinformation.
Fig. 1. COVID-19 mortality in the US, Canada, Europe, Asia, Africa, China, and India. Deaths per Million, per day, averaged over 7 days.
The Lancet Doubles Down on anti-HCQ Fraud
2020-08-25 Mehra et al. was worse than fraud.
On August 22, The Lancet published an editorial Trump versus Biden: a fight for the health of a nation, attacking Trump administration and repeating talking points of the Democrat-Socialist party. For example: “The US must move away from a system in which health care is politicised, contentious, and tied to employment, income, and immigration status. In addition, President Trump’s isolationist and anti-scientific adminstration [sic!] has de-prioritised health and health care.” The Lancet is a British journal. This act is an open and in-your-face interference in the American elections.
The British government might re-consider any support it provides to The Lancet. Scientists, regulatory bodies, and the public in both countries should take notice that The Lancet became a political journal, publishing scientific articles matching its politics, and discount them.
On August 21, The Lancet Rheumatology published another anti-HCQ paper, with a surprisingly similar title to the fraudulent Mehra et al., which was published on May 22 and retracted on June 4. This new paper is titled: Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study. While it might not be be an outright fraud, it is incorrect and produced by dubious methods. Continue reading The Lancet Doubles Down on anti-HCQ Fraud
Google Recommends Bleach
Google recommends bleach for COVID-19:
“Unexpired household bleach will be effective against coronaviruses when properly diluted. Prepare a bleach solution by mixing 5 tablespoons (1/3 cup) bleach per gallon of water”
